{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 2","description":"In part two of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about the latest developments in BTK inhibitors for MS, including safety signals, trial results, and future directions.&amp;nbsp; For more information, please read about the abstract that was presented at the&amp;nbsp;2026 AAN Annual Meeting.&amp;nbsp; Read more about the&amp;nbsp;Fenebrutinib Trial.&amp;nbsp; Disclosures can be found at&amp;nbsp;Neurology.org.&amp;nbsp; ","author_name":"Neurology\u00ae Podcast","author_url":"https:\/\/www.neurology.org\/podcast","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/42270505\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/006d48\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/item\/42270505"}